간행물

생화학분자생물학회입니다.


EMM

Trogocytosis-mediated immune evasion in the tumor microenvironment

  • 작성자

    Jae Hun Shin
  • 작성일자

    2025-03-19
  • 조회수

    1261
Jae Hun Shin ( jaehun.shin@yonsei.ac.kr )
2025-PresentAssociate Professor, Integrated Science & Engineering, Yonsei University
2022-2024Assistant Professor, Integrated Science & Engineering, Yonsei University
2019-2022Post.Doc, Dept. of Immunobiology, Interna Medicine, Yale University
2012-2019PhD, Dept. of Immunobiology, Yale University
2008-2012Research Assistant, National Cancer Center, Korea
2002-2008MS, BSE, Dept. of Biotechnology, Yonsei University

Trogocytosis-mediated immune evasion in the tumor microenvironment

Trogocytosis is a dynamic cellular process characterized by the exchange of plasma membrane and associated cytosol during cell-to-cell interactions. Unlike phagocytosis, this transfer maintains the surface localization of transferred membrane molecules. For instance, CD4 T cells engaging with antigen-presenting cells undergo trogocytosis, facilitating the transfer of antigen-loaded major histocompatibility complex (MHC) class II molecules from the antigen-presenting cells to CD4 T cells, resulting in the formation of antigen-loaded MHC class II molecule-dressed CD4 T cells. These "dressed" CD4 T cells subsequently participate in antigen presentation to other CD4 T cells. Additionally, trogocytosis enables the acquisition of immune-regulatory molecules such as CTLA-4 and Tim3 in recipient cells, thereby modulating their anti-tumor immunity. Concurrently, donor cells undergo plasma membrane loss, and substantial loss can trigger trogocytosis-mediated cell death, termed trogoptosis. This review aims to explore the trogocytosis-mediated transfer of immune regulatory molecules and its implications within the tumor microenvironment, elucidating the underlying mechanisms of immune evasion in cancers.

Exp Mol Med. 2025 Feb;57(1):1-12. doi: 10.1038/s12276-024-01364-2.
https://pubmed.ncbi.nlm.nih.gov/39741180/